Welcome to Cato Research - a full-service contract research and development organization with international resources dedicated to helping pharmaceutical and biotechnology companies efficiently and expeditiously navigate the regulatory approval process in order to bring new drugs, biologics, and medical devices to the people who need them.
Press Releases
-
September 22, 2008 - Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial with Cato Research
-
September 4, 2008 - Cato Research Among Carolina Parent Magazine’s Top 40 Family Friendly Workplaces for a Fourth Time
July 15th, 2008 - Abeome and Cato Research to collaborate on ovarian cancer therapeutic
- More...
